Vancomycin

Displaying 1 - 3 of 3CSV

Zhang, D. A., Stephan, S. R., Cho, R. H., Luong, M., Nigh, E. D., Spine, S., & Poon, S. (2024). The Efficacy of Prophylactic Vancomycin in Decreasing Surgical Site Infections in Adolescent Idiopathic Scoliosis Patients: A Large Multicenter Cohort Study. The Iowa orthopaedic journal, 44(2), 93–99.

Publication Date
Columbia Affiliation
View
PubMed Record
More Information
Ricciuto, A., Liu, K., El‐Matary, W., Amin, M., Amir, A. Z., Aumar, M., Auth, M., Di Guglielmo, M. D., Druve Tavares Fagundes, E., Rodrigues Ferreira, A., Furuya, K. N., Gupta, N., Guthery, S., Horslen, S. P., Jensen, K., Kamath, B. M., Kerkar, N., Koot, B. G. P., … Laborda, T. J. (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium. Alimentary Pharmacology & Therapeutics, 59(10), 1236–1247. Portico. https://doi.org/10.1111/apt.17936
Publication Date
Columbia Affiliation
View
PubMed Record
Scopus Record
Web of Science Record
More Information
Matsumoto, H., Bonsignore-Opp, L., Warren, S. I., Hammoor, B. T., Troy, M. J., Barrett, K. K., Striano, B. M., Roye, B. D., Lenke, L. G., Skaggs, D. L., Glotzbecker, M. P., Flynn, J. M., Roye, D. P., & Vitale, M. G. (2022). Strategies reducing risk of surgical-site infection following pediatric spinal deformity surgery. Spine Deformity, 11(1), 71–86. https://doi.org/10.1007/s43390-022-00559-9
Publication Date
Columbia Affiliation
View
PubMed Record
Scopus Record
Web of Science Record
More Information
CSV